We are a contract research organization
Offers cutting-edge research services and consultancy in the field of liver diseases
We provide tailored reliable solutions to our partners for successful strategic decision making
Previous
Next

The complete pre-clinical Solution

Our services.

BLB is a contract research organization that offers cutting-edge research services
and consultancy in the field of liver diseases.

We provide tailored reliable solutions to our partners for successful
strategic decision making

EXOLIVER®

BLB offers you the possibility to test your drug candidates in a human liver biological system: the unique and patent-protected ExoLiver platform
MORE INFO

TISSUES

BLB gives you the possibility to analyze your favourite gene or protein in liver tissue obtained from rodents and humans
MORE INFO

ORGAN
ON A CHIP

BLB offers high-quality services to create tailored organ on a chip platforms for preclinical human disease modelling
MORE INFO

RODENT
MODELS

BLB provides research services using topquality pre-clinical models of liver disease, including liver cirrhosis, cholestatic liver disease & NASH
MORE INFO

LIVER
CELLS

BLB provides research services using topquality pre-clinical models of liver disease, including liver cirrhosis, cholestatic liver disease & NASH
MORE INFO

STRATEGIC
CONSULTANCY

The virtuous combination of having deep experience in both pre-clinical and clinical phases of liver research
MORE INFO

The news.

Barcelona Liver Bioservices announces partnership with BrudyLab

Barcelona Liver Bioservices (BLB), CRO specialized in the design and development of pre-clinical research in hepatology, announced today a non-exclusive partnership with BrudyLab to explore Brudy’s lead compound DHA as novel therapeutic option for liver disease.

Barcelona Liver Bioservices (BLB) starts operations

Barcelona Liver Bioservices (BLB), a spin-off of IDIBAPS, has been created for the design and development of pre-clinical studies in the fields of hepatology and hepatotoxicity. The co-founders are Jordi Gracia-Sancho, Jaume Bosch and Joan Carles Garcia-Pagan from IDIBAPS and Rosa Villa from CSIC.

Our partners.

Developed with the best partners you can think off

BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.

BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers